Anavex Life Sciences Corp (AVXL)

[nidan7500]

investor:

Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification

In principle sleep could be one biomarker and serve as a surrogate endpoint in a longitudinal P4 post approval study.

Good idea. Might also be used to evaluate combined negative impact on sleep of other prescribed drugs as suggested here.